Product Program year 2024 Source: CMS Open Payments

Accent

Device Cardiac Rhythm Management

PDI 05414734503617

Open in the dashboard

General payments

$669,837

2,690 payments

Research payments

$0

0 payments

Through program year 2024, $669,837 in general payments and $0 in research payments were reported against Accent (Cardiac Rhythm Management).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2024 General $268,895 676
2023 General $212,331 758
2022 General $186,211 1,255
2021 General $2,400 1

Breakdown

Who paid General payments · program years 2021–2024
  1. Abbott Laboratories $669,837 2,690 payments
Top recipients General payments · program year 2024
  1. Zayd Eldadah Clinical Cardiac Electrophysiology · Washington, DC $41,355 15% · 13 payments
  2. Adventhealth Orlando Teaching hospital · FL $15,000 6% · 1 payment
  3. Cyrus Hadadi Cardiovascular Disease · Norfolk, VA $14,673 5% · 13 payments
  4. Ioanna Kosmidou Cardiovascular Disease · New York, NY $14,572 5% · 20 payments
  5. Alexander Drtil Clinical Cardiac Electrophysiology · Houston, TX $10,148 4% · 17 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Clinical Cardiac Electrophysiology Internal Medicine $164,518 68% · 91 practitioners
  2. Cardiovascular Disease Internal Medicine $51,957 22% · 61 practitioners
  3. Interventional Cardiology Internal Medicine $7,576 3% · 24 practitioners
  4. Nephrology Internal Medicine $6,960 3% · 1 practitioner
  5. Internal Medicine $4,039 2% · 10 practitioners

The top 5 of 28 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. District of Columbia $44,162 16% · 6 recipients
  2. New York $26,532 10% · 17 recipients
  3. Pennsylvania $26,463 10% · 14 recipients
  4. Texas $25,607 10% · 34 recipients
  5. Virginia $25,286 9% · 5 recipients

The top 5 of 39 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

2,690 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record